Top 5 Stocks to Buy in 2026 for Long-Term Growth: Renewable Energy, Healthcare, and Real Estate
Brokerages are bullish on a select set of companies across various sectors, including renewable energy, healthcare, real estate, and manufacturing. These companies are expected to offer significant returns in the long term, driven by strong growth visibility, improving business fundamentals, and sectoral tailwinds. Here’s a detailed look at the top 5 stocks to consider for your investment portfolio in 2026.
Shaily Engineering Plastics is one of the standout recommendations from Motilal Oswal Financial Services. The brokerage has maintained a Buy rating on the stock with a target price of Rs 3,404, indicating a potential upside of around 26% from the current market price of Rs 2,695. Shaily Engineering is a leading manufacturer of engineered plastic components and has shown robust performance in recent quarters, driven by increasing demand and cost optimization.
Suzlon Energy, a prominent player in the renewable energy sector, has also received a Buy rating from Motilal Oswal Financial Services. The brokerage has set a target price of Rs 65 for the stock, suggesting a potential upside of nearly 20% from the current market price of Rs 54. Suzlon Energy has been at the forefront of the wind energy revolution in India and is well-positioned to benefit from the growing emphasis on renewable energy and sustainable practices.
Fortis Healthcare, a leading healthcare provider, has been recommended by Choice Institutional Equities with a Buy rating. The target price is set at Rs 1,140, indicating a potential upside of around 17% from the current market price of Rs 970. Fortis Healthcare has a strong network of hospitals and clinics, and the company is expected to benefit from the increasing healthcare needs of the growing population and rising health awareness.
Mahindra Lifespace Developers, a major player in the real estate sector, has been given a Buy rating by Emkay Global. The brokerage has set a target price of Rs 460, which implies a potential upside of approximately 36% from the current market price of Rs 338. Mahindra Lifespace is known for its high-quality residential and commercial projects and has a strong pipeline of upcoming developments, making it a compelling investment opportunity.
Rainbow Children’s Medicare, a specialized healthcare provider focusing on pediatric care, has been recommended by Emkay Global with a Buy rating. The target price is set at Rs 1,550, indicating a potential upside of about 14% from the current market price of Rs 1,350. Rainbow Children’s Medicare has a strong brand presence and is well-regarded for its specialized services, which are in high demand.
These recommendations are based on the strong growth prospects and improving business fundamentals of these companies. Investors looking for long-term gains should consider these stocks as part of their diversified investment portfolio. However, it is always advisable to conduct thorough research and consult with financial advisors before making any investment decisions.
Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times.
